Clinical Trials Logo
  1. Home
  2. Transplant
  3. NCT03691220

Improving Medication Adherence in Adolescents Who Had a Liver Transplant — iMALT  

Transplant Clinical Trial

Official title:
Improving Medication Adherence in Adolescents Who Had a Liver Transplant

Clinical Trial Summary

The study's aim is to test a tailored telemetric intervention to reduce rejection incidence by improving medication adherence in a group of adolescent liver transplant recipients identified as nonadherent by a marker (the Medication Level Variability Index, MLVI).

Clinical Trial Description

This is a prospective, multi-center, randomized controlled trial. The study will be conducted in transplant centers in the United States and Canada. Estimated final sample size of 140 after attrition. Pediatric adolescent and young adult (age at enrollment ≥12 and < 20) transplant recipients will be eligible for participation in the study. Eligible participants will be randomly assigned to intervention or control group. An interim analysis to evaluate efficacy will be performed. Missing data will not be imputed for secondary analyses. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT03691220
Study type Interventional
Source Icahn School of Medicine at Mount Sinai
Contact
Status Active, not recruiting
Phase N/A
Start date November 14, 2018
Completion date October 2024
View Details
See also
  Status Clinical Trial Phase
Active, not recruiting NCT05047068 - OCS Heart Perfusion Post-Approval Registry
Completed NCT03455062 - Fertility Study of Women Who Received Organ Transplantation N/A
Terminated NCT05033548 - Technology Enabled And Molecular Monitoring of the Allograft and Transplant rEcipient
Recruiting NCT04182607 - Donor Outcomes Following Hand-Assisted And Robotic Living Donor Nephrectomy: A Retrospective Review
Completed NCT01022905 - Vaccine Responses to Influenza A H1N1/09 Immunization in High-risk Patients Phase 4
Completed NCT00436384 - Cell Mediated Immunity and the Prediction of CMV Infection In Solid Organ Transplant Recipients Phase 4
Completed NCT00571818 - The Prospective Evaluation of Pancreatic Function in Pancreas Transplant Recipients N/A
Terminated NCT00884039 - Anecortave Acetate Injection to Treat Steroid-responsive Intraocular Pressure Increase in Cornea Transplant Patients N/A
Completed NCT00677677 - Safety and Immunogenicity of Human Papillomavirus (HPV) Vaccine in Solid Organ Transplant Recipients Phase 3
Completed NCT03860818 - Improving Transplant Medication Safety Through A Technology and Pharmacist Intervention N/A
Recruiting NCT04626167 - Concomitant Renal and Urinary Bladder Allograft Transplantation Early Phase 1
Completed NCT01389804 - Parents of Pediatric Solid Organ Transplant Recipients: Transition to Home and Chronic Illness Care N/A
Recruiting NCT04390724 - Optimizing Y90 Therapy for Radiation Lobectomy
Not yet recruiting NCT04690036 - PD-1 Antibody for Reactive EBV After BMT Early Phase 1
Active, not recruiting NCT00152802 - Pneumonia Vaccine in Liver Transplant Recipients: a Booster Strategy Using a Conjugate Vaccine Phase 4
Not yet recruiting NCT05951231 - Liver Transplantation After ex Vivo Liver Perfusion N/A
Completed NCT00242099 - Clinical Utility of Monitoring for Human Herpesvirus-6 (HHV-6) and Human Herpesvirus-7 (HHV-7) After Liver Transplant Phase 4
Recruiting NCT05717842 - Simultaneous Prospective Kidney Transplant Assessment in Combined Liver Kidney Candidates
Recruiting NCT05655546 - ImmunoCARE: Rapid, Accurate COVID Testing to Reduce Hospitalization of Immunocompromised Individuals N/A
Recruiting NCT06161454 - Xofluza-Wearables Feasibility-Study Phase 4